Global Diabetic Nephropathy Market Report, published by Variant Market Research, forecast that the global market is expected to reach $3,826 million by 2024 from $2,410 million in 2016, growing at a CAGR of 5.9% from 2016 to 2024. By geography, Asia-Pacific and Europe are expected to grow at a CAGR of 7.1% and 6.1%, respectively, during the forecast period.

Get Full Access to This Report @ https://www.variantmarketresearch.com/report-categories/pharmaceuticals/diabetic-nephropathy-market

Increasing diabetes and obesity among people, growing investments for drug discovery & development by major companies, increase in number of patients suffering from numerous kidney diseases, and rising awareness among end-users for diabetes disease treatment are some of the primary aspects of global diabetic nephropathy market. However, strict protocols and lengthy product approval procedures for drugs may hamper the growth of the market. Moreover, several initiatives taken by government and NGO’s for increasing alertness for diabetic nephropathy and rising scope of combinational therapies would generate various growth opportunities in the upcoming years.

Get Table of Content (TOC) @ https://www.variantmarketresearch.com/report-categories/pharmaceuticals/diabetic-nephropathy-market/toc

Mode of treatment and geography are the key sections considered in the global diabetic nephropathy market. Mode of treatment is bifurcated into drug modifying therapies {angiotensin receptor blockers (ARBs), angiotensin-converting enzyme (ACE) inhibitor, calcium channel blockers (CCBs), diuretics, renin inhibitors, antioxidant inflammation modulator (AIM), connective tissue growth factor inhibitor (CTGF), monocyte chemoattractant proteins (MCP) inhibitors, endothelin-A receptors antagonist (ETAR), G protein-coupled receptors (GPCRs) and others} and others. Drug modifying therapies is expected to lead the mode of treatment segment with largest market share and fastest CAGR in the forecast period 2016-2024.

North America, Europe, Asia-Pacific, and Rest of the world (RoW) are the major geographical classification of global diabetic nephropathy market. North America dominated the market with largest share of 41.1% followed by Europe with 26.8%, in 2016. In terms of growth, Asia-Pacific is expected to raise with fastest CAGR, due to increasing awareness, presence of high number of diabetic population, and improving healthcare infrastructure.

Click Here to Request a Free Sample PDF of This Report @ https://www.variantmarketresearch.com/report-categories/pharmaceuticals/diabetic-nephropathy-market/sample-request

The major players operating in the market include Novartis AG, Bayer AG, Mallinckrodt Pharmaceuticals, Reata Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation, Mesoblast Ltd., ChemoCentryx Inc., Ampio Pharmaceuticals Inc., Eli Lilly and Company, GenKyoTex S.A., and among others.

Scope of the Global Diabetic Nephropathy Market
Mode of Treatment Segments
• Drug Modifying Therapies (DMT)
o Angiotensin-Converting Enzyme (ACE) Inhibitor
o Angiotensin Receptor Blockers (ARBs)
o Diuretics
o Calcium Channel Blockers (CCBs)
o Renin Inhibitors
o Connective Tissue Growth Factor Inhibitor (CTGF)
o Antioxidant Inflammation Modulator (AIM)
o Monocyte Chemoattractant Proteins (MCP) Inhibitors
o Endothelin-A Receptors Antagonist (ETAR)
o G Protein-Coupled Receptors (GPCRs)
o Other Drug Modifying Therapies

• Other Mode of Treatments

Geography Segments
• North America
o U.S.
o Canada
o Mexico

• Europe
o UK
o Germany
o France
o Italy
o Other

• Asia-Pacific
o China
o Japan
o India
o South Korea
o Others

• RoW
o South America
o Middle East
o Africa

About Variant Market Research
Variant Market Research offers syndicated and customized reports to fulfill clients' objectives. We also provide customized data pack proposing market sizing in an Excel/PDF/PowerPoint or Word format as per the requirement of clients. We cover several industry domains, namely Semiconductor & Electronics, Consumer Electronics, Information and Communication Technology, Automotive, Consumer Goods, Food & Beverages, Pharmaceuticals, Medical Devices, Chemicals, Industrial, Mining Equipment, Automation, Manufacturing, Construction, Energy & Power, Defense & Aerospace and Banking, Financial services and Insurance (BFSI). Our expertise are data triangulation, competitor benchmarking, parent market benchmarking, estimating market size and forecast of the market from 2016 to 2024.
For further information, visit https://www.variantmarketresearch.com

Contact Us:
Variant Market Research
Web: https://www.variantmarketresearch.com
Tel: +1-415-680-2785
Tel: +91 20 65337795
Fax: +1-415-680-2786
Email: [email protected]
Email: [email protected]